Published in Clin Ophthalmol on October 16, 2012
The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients. Ther Clin Risk Manag (2013) 0.86
Retinal sensitivity assessed by microperimetry and corresponding retinal structure and thickness in resolved central serous chorioretinopathy. Eye (Lond) (2014) 0.80
Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc (2015) 0.75
Structural and Functional Outcomes in Chronic Central Serous Chorioretinopathy Treated with Photodynamic Therapy. Korean J Ophthalmol (2015) 0.75
Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina (2003) 2.90
Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol (2003) 2.25
Photodynamic therapy for chronic central serous chorioretinopathy. Retina (2003) 2.20
Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology (2008) 1.88
Histopathological changes following photodynamic therapy in human eyes. Arch Ophthalmol (2002) 1.75
Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol (2002) 1.61
Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. Am J Ophthalmol (2009) 1.41
Fundus perimetry with the Micro Perimeter 1 in normal individuals: comparison with conventional threshold perimetry. Ophthalmology (2005) 1.30
Characteristics of visual loss by scanning laser ophthalmoscope microperimetry in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol (2003) 1.21
Central serous chorioretinopathy: bilateral multifocal electroretinographic abnormalities. Arch Ophthalmol (1999) 1.17
Retinal sensitivity measured with the micro perimeter 1 after resolution of central serous chorioretinopathy. Am J Ophthalmol (2008) 1.12
Assessment of macular function by microperimetry in unilateral resolved central serous chorioretinopathy. Eye (Lond) (2006) 1.10
Retinal dysfunction in central serous retinopathy. Eye (Lond) (1987) 1.00
Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results. Retina (2011) 0.99
Microperimetric changes after photodynamic therapy for central serous chorioretinopathy. Am J Ophthalmol (2010) 0.95
Local macular electroretinographic responses in idiopathic central serous chorioretinopathy. Am J Ophthalmol (1988) 0.92
Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy. Br J Ophthalmol (2010) 0.91
Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion. Retina (2010) 0.90
Visual function abnormalities in central serous retinopathy. Arch Ophthalmol (1984) 0.89
Low-fluence photodynamic therapy in longstanding chronic central serous chorioretinopathy with foveal and gravitational atrophy. Eur J Ophthalmol (2009) 0.89
Retinal thickness and perimetric sensitivity in central serous chorioretinopathy. Jpn J Ophthalmol (2010) 0.87
Intravitreal bevacizumab versus the conventional protocol of photodynamic therapy for treatment of chronic central serous chorioretinopathy. Acta Ophthalmol (2011) 0.86
Functional retinal changes measured by microperimetry in standard-fluence vs low-fluence photodynamic therapy in chronic central serous chorioretinopathy. Am J Ophthalmol (2011) 0.86
Color vision defects after central serous chorioretinopathy. Retina (2000) 0.84
Comparing fixation location and stability in patients with neovascular age-related macular degeneration treated with or without Ranibizumab. Eye (Lond) (2010) 0.82
[Studies on local electric response of the human retina. VI. Macular ERGs of a typical central serous retinopathy]. Nippon Ganka Gakkai Zasshi (1970) 0.78
Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol (2009) 4.39
Reduction of anterior chamber contamination rate after cataract surgery by intraoperative surface irrigation with 0.25% povidone-iodine. Am J Ophthalmol (2010) 3.14
Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci U S A (2006) 2.40
Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology (2010) 2.39
Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment. Retina (2013) 2.17
The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography. Retina (2011) 2.12
Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology (2009) 2.02
Expanded indications for 25-gauge transconjunctival vitrectomy. Jpn J Ophthalmol (2005) 1.57
Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol (2010) 1.52
Complement factor H polymorphisms in Japanese population with age-related macular degeneration. Mol Vis (2006) 1.51
Reduced choroidal blood flow can induce visual field defect in open angle glaucoma patients without intraocular pressure elevation following encircling scleral buckling. Retina (2008) 1.50
Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). FASEB J (2005) 1.47
Subjective visual sensation during vitrectomy under retrobulbar anesthesia. Am J Ophthalmol (2006) 1.46
Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health Qual Life Outcomes (2005) 1.45
Visual Sensations during Vitrectomy. Ophthalmology (2006) 1.44
Fundus autofluorescence and optical coherence tomographic findings in acute zonal occult outer retinopathy. Retina (2010) 1.44
Retinal neurodegeneration in the DBA/2J mouse-a model for ocular hypertension. Acta Neuropathol (2004) 1.44
Dose of intravitreal bevacizumab (Avastin) used as preoperative adjunct therapy for proliferative diabetic retinopathy. Retina (2010) 1.43
Frequency, source, and prevention of cotton fibers in the anterior chamber during cataract surgery. J Cataract Refract Surg (2008) 1.43
Factors influencing visual outcome of polypoidal choroidal vasculopathy one year after photodynamic therapy. Graefes Arch Clin Exp Ophthalmol (2010) 1.43
Images of intravitreal objects projected onto posterior surface of model eye. Acta Ophthalmol (2013) 1.42
Indocyanine green can distinguish posterior vitreous cortex from internal limiting membrane during vitrectomy with removal of epiretinal membrane. Retina (2002) 1.41
Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy. Ophthalmology (2010) 1.38
Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci (2008) 1.34
Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation. Invest Ophthalmol Vis Sci (2006) 1.24
Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era. Cancer Sci (2009) 1.22
Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy. Am J Ophthalmol (2012) 1.21
Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthalmol Vis Sci (2008) 1.21
Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy. Am J Ophthalmol (2006) 1.20
Intrinsic signal imaging in macaque retina reveals different types of flash-induced light reflectance changes of different origins. Invest Ophthalmol Vis Sci (2007) 1.20
A homozygosity-based search for mutations in patients with autosomal recessive retinitis pigmentosa, using microsatellite markers. Invest Ophthalmol Vis Sci (2004) 1.20
Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy. Retina (2008) 1.19
Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes (2008) 1.19
Incidence of endophthalmitis after 20- and 25-gauge vitrectomy causes and prevention. Ophthalmology (2008) 1.18
Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci (2005) 1.18
Polypoidal choroidal vasculopathy: simultaneous indocyanine green angiography and eye-tracked spectral domain optical coherence tomography findings. Retina (2012) 1.16
Choroidal thickness and visual acuity in highly myopic eyes. Retina (2012) 1.14
HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration. Mol Vis (2007) 1.14
Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy. Jpn J Ophthalmol (2011) 1.14
Transcorneal electrical stimulation of retina to treat longstanding retinal artery occlusion. Graefes Arch Clin Exp Ophthalmol (2007) 1.13
Genetic analysis of typical wet-type age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese population. J Ocul Biol Dis Infor (2009) 1.13
Double staining with brilliant blue G and double peeling for epiretinal membranes. Ophthalmology (2009) 1.12
25-gauge scleral tunnel transconjunctival vitrectomy. Am J Ophthalmol (2006) 1.12
Massive bilateral vitreoretinal hemorrhage in patient with chronic refractory idiopathic thrombocytopenic purpura. Graefes Arch Clin Exp Ophthalmol (2005) 1.09
Multimodal fundus imaging of pseudoxanthoma elasticum. Retina (2011) 1.08
Relation between stage of endogenous fungal endophthalmitis and prognosis. Graefes Arch Clin Exp Ophthalmol (2005) 1.07
[Clinical effects of photodynamic therapy with Verteporfin for age-related macular degeneration 1: three-month results]. Nippon Ganka Gakkai Zasshi (2006) 1.07
Nephrotic syndrome complicated by idiopathic central diabetes insipidus. Pediatr Nephrol (2014) 1.07
Retinal dysfunction and progressive retinal cell death in SOD1-deficient mice. Am J Pathol (2008) 1.07
Cell cycle suspension: a novel process lurking in G₂ arrest. Cell Cycle (2011) 1.07
[Assessment of the quality of life of patients with age-related macular degeneration after photodynamic therapy]. Nippon Ganka Gakkai Zasshi (2006) 1.07
Patients' descriptions of visual sensations during pars plana vitrectomy under retrobulbar anesthesia. Am J Ophthalmol (2007) 1.06
Effect of bevacizumab on inflammation and proliferation in human choroidal neovascularization. Arch Ophthalmol (2008) 1.05
Outer retinal microstructure in a case of acute idiopathic blind spot enlargement syndrome. Case Rep Ophthalmol (2011) 1.03
Visual recovery after vitrectomy for macular hole using 25-gauge instruments. Acta Ophthalmol (2007) 1.03
Extracellular ubiquitination and proteasome-mediated degradation of the ascidian sperm receptor. Proc Natl Acad Sci U S A (2002) 1.03
Role of photodynamic therapy in polypoidal choroidal vasculopathy. Jpn J Ophthalmol (2007) 1.03
Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. Br J Haematol (2008) 1.03
Fundus autofluorescence in autosomal dominant occult macular dystrophy. Arch Ophthalmol (2011) 1.02
Intravitreal bevacizumab therapy for idiopathic macular telangiectasia. Jpn J Ophthalmol (2010) 1.02
Correlation between indocyanine green angiographic findings and histopathology of polypoidal choroidal vasculopathy. Jpn J Ophthalmol (2004) 1.01
Investigation of thermal effects of infrared lasers on the rabbit retina: a study in the course of development of an active subretinal prosthesis. Graefes Arch Clin Exp Ophthalmol (2007) 1.00
Outcomes of visual acuity in carbon ion radiotherapy: analysis of dose-volume histograms and prognostic factors. Int J Radiat Oncol Biol Phys (2005) 1.00
Seventeen cases of central serous chorioretinopathy associated with systemic corticosteroid therapy. Ophthalmologica (2004) 1.00
Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results. Retina (2011) 0.99
Respiratory failure caused by intrathoracic amoebiasis. Infect Drug Resist (2010) 0.99
Decreased blood flow at neuroretinal rim of optic nerve head corresponds with visual field deficit in eyes with normal tension glaucoma. Graefes Arch Clin Exp Ophthalmol (2005) 0.98
Residual crystals of triamcinolone acetonide in macular hole may prevent complete closure. Acta Ophthalmol Scand (2007) 0.98
Retinal circulatory disturbances following intracameral injection of bevacizumab for neovascular glaucoma. Acta Ophthalmol (2008) 0.98
[Reading performance in patients with central visual field disturbance due to glaucoma]. Nippon Ganka Gakkai Zasshi (2006) 0.98
Clinical characteristics of occult macular dystrophy in family with mutation of RP1l1 gene. Retina (2012) 0.97
Subretinal electrical stimulation of the rabbit retina with acutely implanted electrode arrays. Graefes Arch Clin Exp Ophthalmol (2004) 0.96
Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes. Invest Ophthalmol Vis Sci (2005) 0.96
Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy. BMC Ophthalmol (2014) 0.96
Focal functional and microstructural changes of photoreceptors in eyes with acute zonal occult outer retinopathy. Case Rep Ophthalmol (2011) 0.95
Rescue of axotomized retinal ganglion cells by BDNF gene electroporation in adult rats. Invest Ophthalmol Vis Sci (2002) 0.95
Intraoperative breakage of a 25-gauge vitreous cutter. Am J Ophthalmol (2004) 0.95
Haplotype analysis of the human renin gene and essential hypertension. Hypertension (2003) 0.95
Transcriptional factors associated with epithelial-mesenchymal transition in choroidal neovascularization. Mol Vis (2011) 0.94
In situ confirmation of retinal blood flow improvement after carotid endarterectomy in a patient with ocular ischemic syndrome. Am J Ophthalmol (2002) 0.94
Unusual protrusion of conjunctiva in two neonates with harlequin ichthyosis. Case Rep Ophthalmol (2011) 0.93